Citigroup Maintains Buy on SHC (Sotera Health Company) Feb 24 2026, PT $23
Citigroup maintains Buy and raises SHC price target to $23; read our SHC analyst rating breakdown
-
-
RRSECUR.BO R R Securities BSE pre-market Feb 2026 44.92: Oversold bounce to 77.90
Pre-market note: RRSECUR.BO stock at INR 44.92 on Feb 2026 shows oversold bounce setup and Meyka AI forecast to INR 86.93
-
ALIMP.PA Implanet S.A. EURONEXT up 15.87% pre-market 25 Feb 2026: check forecast
Pre-market top-gainer ALIMP.PA stock up 15.87% to €0.23 on 25 Feb 2026; Meyka forecast shows 53.83% 1-year upside
-
FDX Stock Today: February 25 – Tariff Refund Lawsuit Sets Precedent
FedEx tariff refund lawsuit after the Supreme Court tariff ruling could trigger CBP duty repayments and reshape cash flows. What it means for FDX and Japan-based importers today.
-
JPY 425.00 intraday bounce in 3319.T (Golf Digest Online, JPX) 25 Feb 2026: watch 440
Intraday oversold bounce on 3319.T stock at JPY 425.00; quick technicals, Meyka AI grade and a JPY 540 forecast
-
Earnings due 25 Feb 2026: SUNeVision 1686.HK (HKSE) HK$6.24 preview
Pre-market earnings preview for 1686.HK stock: SUNeVision at HK$6.24 with Meyka AI forecast and valuation insight
-
COFORGE.NS Stock Today: February 25 – AI Rout; CLSA Favors Coforge
Coforge share price slid nearly 6% as Nifty IT index fell on AI disruption fears. CLSA says worries look overdone, keeping Coforge among preferred picks. Key levels, data, outlook.
-
Pre-market SK6U.SI SPH REIT (SES) S$0.98 25 Feb 2026: Oversold bounce setup
Pre-market oversold bounce on SK6U.SI stock at S$0.98; Meyka AI projects S$1.13 (15.31% upside)
-
Volume 273,930 in QBTL.TO AGFiQ US Market Neutral TSX Feb 2026: Watch CAD 14.54
Volume spike in QBTL.TO stock on TSX to 273,930 shares at CAD 14.54; Meyka AI volume-driven analysis and forecasts
-
February 25: Measles Alert at Sydney Airport Hits Travel Demand
Sydney Airport alert sparks search interest in measles symptoms. What Singapore travelers and investors should watch today: route updates, health checks, MMR vaccine guidance, and insurance signals.
